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Abstract Heterotrimeric (c&) guanine nucleotide binding 
proteins (G-proteins) dissociate into their constituent subunits 
in the course of signal transduction. Exposure of the G-protein 
G, to the h-specific monoclonal antibody 3E7 results in 
recovery of a, alone. We identified the 3E7 epitope as 
ERSKAIEKNL (positions 1423) using synthetic peptides and 
phage display. G, isolated with h-specific monoclonal antibodies 
MONO and 3C2 dissociates and releases its fir subunits when 
exposed to 3E7. Exposure to 3E7, but not MONO or 3C2, 
results in the displacement of & from trimers, in the absence of 
added activators of G-proteins (GTPyS, Mg2+A1F4-). We 
propose that stable binding of 3E7 to a,, requires displacement 
of &r and occurs in the absence of guanine nucleotide exchange. 
Key words: Trimeric G-protein; Monoclonal antibody; 
Antibody-induced dissociation; Guanine nucleotide 
1. Introduction 
G-proteins (a (39-52 kDa), p (35-36 kDa) and y (8-12 
kDa)) transduce signals from cell surface receptors to their 
downstream effecters [l-4]. Their function is not limited to 
the cell surface: substantial evidence implicates G-proteins 
in intracellular membrane transport events [5-71. G-proteins 
have been localized to subcellular domains such as caveolae 
and Golgi membranes [8,9]. Reconciling the prevailing view 
on G-protein-mediated signalling with the existence of intra- 
cellular pools of G-protein subunits involved in transport is a 
challenging cell biological problem. GTP@ and AlF*-, com- 
monly used activators of trimeric G-proteins, block intra-Gol- 
gi transport. How activation occurs in the course of G-pro- 
tein-mediated transport is not known. It has been suggested 
that trimeric G-proteins may interfere with coatomer binding 
to intracellular membranes [7]. 
Activation of G-proteins by ligand-occupied receptors at 
the plasma membrane catalyzes the exchange of a-bound 
GDP for GTP, resulting in dissociation of the heterotrimer 
and the release of pr. Both a and Pr can then regulate down- 
stream effecters [lO,l 11. A recent study showing activation of 
an effector by a G-protein in the absence of GDP/GTP ex- 
change or GTPase activity suggests that activation can occur 
by other means [12]. 
We have assessed the quaternary structure of the G-protein 
G,, originally identified as the major pertussis toxin substrate 
in bovine brain [13-151, by using monoclonal antibodies 
(mAbs) which recognize trimeric and monomeric forms of 
a, [16]. We mapped the epitope recognized by mAb 3E7 
and localized it to the amino residues 14-23 of the a subunit. 
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The structures of Gi and Gt, as determined by X-ray crystal- 
lography, confirm this region as a putative by-binding site in cx 
subunits [ 16,171. Exploiting the ability of two additional mAbs 
MONO and 3C2 to bind G, trimers, we show here that ex- 
posure of Go-antibody complexes to 3E7 results in the re- 
moval of &. We suggest that the release of fir by 3E7 is 
best explained by 3E7 and Pr interacting with the same site 
on a,. These results allow the conclusion that dissociation of 
trimeric G-proteins does not absolutely require GDP/GTP 
exchange, and could conceivably be accomplished by cellular 
proteins that interact with this segment of the G-protein c1 
subunit. 
2. Materials and methods 
2.1. Preparation of membranes and immunoafinity matrices 
Bovine brain membranes and highly purified G-proteins were as 
previously described [18]. mAbs MONO, 3C2 and 3E7 (IgG1 isotype) 
[18] were immobilized on CNBr-activated Sepharose4B beads by 
covalent coupling methods described by the manufacturer (Pharma- 
cia) or bound to protein A-Sepharose beads and covalently cross- 
linked [19]. 
2.2. Biochemical analysis 
G-proteins were extracted from bovine brain membranes in cold 
Nonidet P-40 lvsis buffer (0.5% Nonidet P-40. 50 mM Tris-HCl. DH 
7.3, and 5 rnG MgCl2) Supplemented with ‘50 mM NaCl, 1 ‘AM 
PMSF and 0.1% Lubrol for 2 h at 4°C. Lysates were clarified by 
centrifugation at 14000 rpm for 20 min prior to immunoprecipita- 
tions, which were typically carried out for 90 min at 4°C. Immune 
complexes were isolated, washed with cold NET buffer (0.5% Nonidet 
P-40, 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA) and 
prepared for SDS-PAGE [20]. Polypeptides were visualized by silver 
staining [21]. In some experiments, Nonidet P-40 lysates of bovine 
brain membrane preparations were applied to MONO or 3C2 affinity 
matrices at 4°C to immobilize G,. The G,-mAb isolated complex was 
washed with Nonidet P-40 lysis buffer and then equilibrated with 
buffer A (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM DTT, 2 
mM MgS04, 100 mM NaCl, 0.05% (w/v) Lubrol-PX (Sigma)). Spe- 
cific elution of &was carried out with buffer A containing guanosine 
5’-3-O-(thio)triphosphate (GTPyS) or 3E7 as described in the figure 
legends. 
2.3. Peptide synthesis and analysis 
Peptides were synthesized on a multiple peptide synthesizer (model 
350: Advanced Chemtech, Louisville. KY). usine. conventional Fmoc 
I .  _  
chemistry. Peptides were dissolved in 0.1 X phosphate buffered saline 
(PBS) and filtered through 0.22 mm filters [22]. Peptide concentrations 
were determined by absorbance at 275.5 nm and stored in 0.1 M 
borate buffer, pH 10 approximately at 1 mg/ml [23]. ELISAs and 
peptide competition assays were performed using the standard ELISA 
procedure and are as described in the figure legends [18]. The fd-tet 
M 13 phage peptide library was prepared from a vector containing the 
fd-tet phage and the tetracycline gene [24]. Immunoprecipitations 
from the fd-tet 15mer library containing 6X lOlo phage units in 0.5 
ml of Nonidet P-40 lysis mix were carried out with 3E7. Immune 
complexes eluted with glycine HCI, pH 2.2 were used to infect K91 
(kanamycin resistant) cells at room temperature. Phage particles were 
isolated from infected cells selected in the presence of 20 @ml tetra- 
0014-5793/96/$12.00 0 1996 Federation of European Biochemical Societies. All rights reserved. 
PIISOOl4-5793(96)00441-3 
M. Yilla et al.IFEBS Letters 387 (1996) 16-22 17 
cycline. The 3E7-selected phage particles were further amplified 
through two more rounds of immunoprecipitations, infections and 
phage isolation steps. Single stranded DNA particles were isolated 
from the final amplified phage library and sequenced [25]. 
3. Results 
3.1. IdentiJication of the 3E7 epitope 
Two independent procedures were used to map the epitope 
recognized by the cc,,-specific mAb 3E7. Peptides spanning 
residues l-90 of the amino terminus of a,, each 10 amino 
acids long, were synthesized using standard Fmoc chemistry. 
The sequences of the first six peptides are shown in Fig. 1A. 
The peptides were each tested for reactivity with 3E7 by ELI- 
SA. One peptide, Ala’1-Glu25 of sequence AALERS- 
KAIEKNLKE, was substantially more reactive with 3E7 
than any of the other peptides tested (Fig. 1B). In an ELISA 
assay using immobilized G-proteins on the plate, Ala1i~Gluz5 
was the only peptide which competed significantly with 3E7 
for binding to the immobilized G-proteins (Fig. 1C). From 
these results, the epitope for 3E7 was localized to residues 
11-25 in the amino terminus of &. 
The 3E7 epitope was confirmed and further narrowed down 
by using an Ml3 phage display peptide library [24] to identify 
sequences of random peptides recognized by 3E7. The motifs 
obtained from sequencing single stranded DNA isolated from 
affinity-purified phage, as described in Section 2, are shown in 
Fig. 1D. The motif ERxxAxxxNL was common to 80% of the 
clones tested. Importantly, this completely independent strat- 
egy identified a segment of a, wholly contained in the Alall- 
G1uz5 peptide. The arginine at position 21 was present in all 
phage clones tested, though absent in the published sequence 
of a,. The ability of 3E7 to discriminate between various a 
subunits was shown previously [18] and may be due to the 
presence of the alanine at position 18 (Ala’*), although we 
have not investigated this further. We propose that the epi- 
tope recognized by 3E7 on a, is “ERSKAIEKNL23. 
3.2. 3E7 induces dissociation of G,, (a&r) trimers 
The epitope recognized by 3E7 resides in a region of a 
shown to bind Py in other G-proteins [16,17]. In immunopre- 
cipitations, mAbs MONO and 3C2 immunoprecipitate stable 
heterotrimeric complexes of aO, p and y subunits from prep- 
arations of G-proteins ([18,26]; see Fig. 2A, antibodies 
MONO and 3C2)(‘). In contrast, 3E7 immunoprecipitates a, 
free of any associated Py (Fig. 2A, antibody 3E7). 3E7 may 
recognize only a subunits that have spontaneously released 
their By subunits. Since afly are in equilibrium (Z& of a, for 
binding Py was reported as 340-390 nM [27], but see [26]), 
3E7 could potentially bind free a during trimer dissociation 
and by virtue of its high affinity prevent Py reassociation. 
Alternatively, 3E7 might interact with a,, by first inducing 
the release of By from the trimeric complex. Therefore trimers 
immobilized on 3C2 matrices were exposed to 3E7 in solution. 
G, was first collected from solubilized brain membrane ex- 
tracts with 3C2 (Fig. 2B, 1st antibody 3C2). The By subunits 
were co-immunoprecipitated by virtue of their association 
with a. Incubation of G, with 3E7 resulted in the dissociation 
(‘IThe specificity of the antibodies for cc,, and the assignment of a and 
p proteins has been published [lg]. The y subunits are not visualized 
under these electrophoretic conditions but can be readily seen on Trisl 
tricine gels (Rehm, Bogyo and Ploegh, unpublished data). 
of all Py subunits (Fig. 2B, 1st antibody 3C2, 2nd antibody 
3E7). The fly subunits were released into the supernatant, as 
revealed by immunoblot analysis with polyclonal serum reac- 
tive with a,, p and y subunits (Fig. 2C, 1st antibody 3C2, 2nd 
antibody 3E7). No loss of a from the 3C2-G, complex was 
detected (Fig. 2C; 1st antibody 3C2, 2nd antibody 3E7). As 
control, a purified a,lor mixture is shown in both figures (Fig. 
2B,C, Pur G). Previous reports have shown that a,-GDP has 
a high affinity for By when bound to MONO or 3C2, such 
that spontaneous dissociation of the trimer is not observed 
[28]. It is therefore likely that it is the binding of 3E7 to its 
epitope that displaces /3y from G,. 
We examined the stability of the trimer in the presence of 
two mAbs interacting simultaneously with the a subunit. We 
exposed Nonidet P-40 detergent lysates prepared from brain 
membranes to 3E7 and then scored for the effect on G, seen 
by MONO or 3C2. Lysates were first incubated with 3E7 (Fig. 
2D, 1st antibody, 3E7) and following removal of 3E7 immune 
complexes, residual G-protein subunits were immunoprecipi- 
tated with MONO (Fig. 2D, 1st antibody 3E7, 2nd antibody 
MONO) or with 3C2 (Fig. 2D, 1st antibody 3E7, 2nd anti- 
body 3C2). Under these experimental conditions, no By sub- 
units were recovered with MONO or 3C2 (Fig. 2D). Both 
MONO (or 3C2) and 3E7 can interact simultaneously with 
cl,. 3E7 readily precipitates free a, (generated by treatment of 
lysates with GTPyS), indicating that the presence of Py is not 
necessary for the antibody to bind a,, [18]. Exhaustive immu- 
noprecipitation of lysates with 3E7 removes all a subunits 
reactive with MONO or 3C2 (Fig. 2E, see MONO or 3C2 
following three sequential 3E7 immunoprecipitations). While 
it is possible that 3E7 binds free a and subsequently shifts the 
equilibrium such that only free as are available to interact 
with MONO and 3C2, we favor the interpretation that asso- 
ciation of 3E7 with a alters the interaction of a, with By and 
results in dissociation of the trimeric complex. 
3.3. Comparison of dissociation of G-proteins by 3E7, with 
GTpVs 
The efficiency of dissociation induced by 3E7 was compared 
with that of the nonhydrolyzable GTP analogue, GTPyS. Sim- 
ilar results were obtained with MgAlF4- (data not shown). G,, 
was collected from Nonidet P-40 detergent lysates with 
MONO-beads as described in the figure legend (Fig. 3A, 
MONO-isolated G,). G, was washed extensively and then 
treated with either GTPyS, 3E7 or with 3C2. As expected, 
GTPyS induced dissociation of G, and caused the release of 
all Py subunits (Fig. 3A, GTPyS treatment). 3E7 induced re- 
lease of the majority of the By subunits in the MONO-isolate 
(Fig. 3A, 3E7 treatment). Note the appearance of the 3E7 
light chain in the immunoprecipitate (Fig. 3A, 3E7 treatment), 
as indicator that a, immobilized on MONO, can interact si- 
multaneously with 3E7. Eluants from a MONO-protein A- 
Sepharose column treated with either 3E7 or GTPyS showed 
near identical elution profiles (Fig. 3B). Exposure to 3C2 re- 
sulted in release of the trimer from the MONO-isolate (Fig. 
3A, 3C2 treatment). We ascribe this to competition between 
the mAbs for their closely spaced epitopes, such that excess 
3C2 (residues 80-145, 100-103 in particular [18]) in solution 
displaces G, from MONO (residues 80-145 [18]; see Fig. 2C, 
1st antibody MONO, 2nd antibody 3C2). We conclude that 
like GTPyS, 3E7 treatment of G,, results in the physical sep- 
aration of a and By subunits. 
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Fig. 1. Epitope on ~6 recognized by 3E7. A: Six of 16 overlapping 15mer peptides synthesized from CL, amino acids l-90 are shown. B: 15mer 
peptides were plated at 0.1 @ml on ELISA plates and incubated with 50 j.tl of 3E7 hybridoma supernatant. The absence of bars for some pep- 
tides indicates no significant signal above background. C: 0.5 ug of purified G,/Gi mixtures were immobilized on ELISA plates and then ex- 
posed to 50 pl of a mixture containing 3E7 hybridoma supernatant and 0.25 pg of each peptide. All ELISA experiments were done in triplicate 
and the average ODsss recorded. D: The proposed motif recognized by 3E7 based on phage display is given at the top. Conserved residues pre- 
sent in 10 phage clones used to construct the motif are capitalized. In bold are those residues found in ~6. Amino acids found in the 10 clones 
at other positions are in lower case. The table below the consensus motif lists the different a isotype sequences. An exact match of the motif 
with any other a subunit sequence with the motif is given in bold and an asterisk indicates residues shared with o_,. The residues in italics (po- 
sitions 14, 15, 18 and 22) are substitutions that may preclude reactivity with 3E7. The residues occurring at positions 19 and 21 of the phage 
display motif occur as conservative substitutions in a, (Leu-Be and Arg-Lys, respectively). We obtain a match of 8/l 1 residues for the 3E7 mo- 
tif with a0 if these conservative substitutions are included. The sequences are bovine ~6 [33], rat a, [34], rat [35], a12 [36], ais [37], bovine pi, 
~a, rat a, [37]. 
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Fig. 2. Go-antibody interactions. A: Non-denaturing Nonidet P-40 lysates of bovine brain membranes were immunoprecipitated with MONO, 
3C2 and 3E7 and the immune complexes collected on Staph. A. Eluted samples were loaded on a 10% SDS-polyacrylamide gel and the poly- 
peptide chains visualized by silver staining. The positions of immunoglobulin heavy (HC) and light (LC) chains, and the G-protein subunits, a, 
(39 kDa) and B (refers to Bl (36 kDa) and B2 (35 kDa)), are indicated on the right of this and subsequent figures. B: Nonidet P-40 lysates of 
bovine brain membranes were immunoprecipitated with 3C2 for 60 min at 4°C and the immune complexes washed once with NET buffer. The 
isolated complex was then incubated with excess 3E7 (at 1 mg/ml) for an additional 60 min at 4°C. Input G-protein for each precipitation was 
180 pg. Heptylamine-Sepharose purified G-proteins (Pur G), direct precipitation with 3C2 (1st antibody 3C2), 3C2-reactive G, treated with 3E7 
(1st antibody 3C2, 2nd antibody 3E7). The G-protein cli (41 kDa) is indicated. C: Immunoblot analysis of the supernatants. Blots were probed 
with a bovine G-protein polyclonal serum reactive against CL, B and y subunits. D: Lysates were depleted of 3E7-reactive material for 60 min at 
4°C and the 3E7-immune complexes collected on Staph. A. The resulting supernatant was immunoprecipitated with MONO or with 3C2. Direct 
precipitation with 3E7 (1st antibody 3E7), MONO precipitation after 3E7 depletion (1st antibody 3E7, 2nd antibody MONO) or directly (1st 
antibody MONO), 3C2 precipitation after 3E7 depletion (1st antibody 3E7, 2nd antibody 3C2), or directly (1st antibody 3C2). E: Membrane 
lysates were immunoprecipitated overnight with 3E7 and then through two subsequent rounds of precipitations with the same antibody. The 
3E7-depleted lysate was then immunoprecipitated with MONO or with 3C2. 
4. Discussion 
We have shown here that rnAb 3E7 interacts with G-pro- 
teins via residues 14-23 on the CY subunit. Trimers of G, 
challenged with 3E7 in solution release their fly subunits, in 
the absence of guanine nucleotide exchange. Since GTP was 
not added to the incubations, and since purified G-proteins 
occur exclusively in the GDP-liganded state, GTPase activity 
cannot play a role in the dissociation of & observed here. An 
anti-transducin mAb 4A was previously described whose ef- 
fects are similar to those of 3E7 [29-311. The affinity of CQ for 
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By is known to be substantially reduced when compared to 
other G-proteins, and it is the one G-protein for which dis- 
sociation in response to GTP (as opposed to GTPyS) has been 
shown [39]. The ability to raise antibodies of the type exem- 
plified by 3E7 and 4A suggest that in a sizable proportion of 
the G-proteins in the immunogen, the respective epitopes 
must have been accessible. These observations are consistent 
with a dynamic interaction between a and By. 
It could be argued that since c1 and By are in rapid equilib- 
rium, 3E7 binds to free o! in an irreversible manner and this 
generates free By subunits (see Fig. 4, model IIA). Formally, 
we cannot discriminate between this possibility and that of 
antibody-induced dissociation in some of our experiments 
(Fig. 4, model IIB). However, our biochemical data (Figs. 2 
and 3) show that 3E7 can bind to G, captured as stable 
trimers by MONO and 3C2, and in doing so displace their 
By subunits (Fig. 4, model I). From this it may be inferred 
that binding of 3E7 and By is non-equivalent. This is not 
altogether unexpected, because fir interacts with a subunits, 
at least in the case of % and CLi in regions other than the N- 
terminus as well [16,17]. Since 3E7 does not readily dissociate 
from a, it eventually displaces all the By subunits bound to a. 
Binding of 3E7 may thus exclude rebinding of By. The 3E7 
epitope does lie within the putative & binding region. 
How does 3E7 release fir? We consider two possibilities 
summarized in Fig. 4. to explain the observed displacement 
of 07 by 3E7. In the first possibility, 3E7 binds to a site that is 
adjacent to the region of CI that contacts By. By binding of 
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rMono-isolated Go1 
Treatment - GTPyS 3E7 3C2 Pur G 
Fig. 3. Comparison of Pr release induced by 3E7, with GTPy S. A: 
Nonidet P-40 lysates of bovine brain membranes were immunopreci- 
pitated with MONO cross-linked to CNBr-activated Sepharose 
beads (MONO-beads). The MONO-isolated G, (no treatment) was 
washed as described in the methods and then treated with either 0.5 
mM GTP@, 3E7 or 3C2 in buffer A. 3 pg of heptylamine-Sephar- 
ose purified G-proteins were loaded as control (Pur G). a indicates 
a, (39 kDa), and a; (41 kDa), present in the Pur G lane. B: Eluted 
fractions from an independent experiment are shown. G-proteins 
isolated on MONO-Sepharose beads were extensively washed as de- 
scribed and then eluted with 50 PM GTPys or 100 &ml of 3E7. 
t 
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3E7 Treatment 
GTPyS Treatment 
3E7, the conformation of the py-interacting segment of a is 
altered such that dissociation is favored. In this scenario, the 
antibody would bind to the trimer, affect the by-binding seg- 
ment, and lead to loss of /3r by favoring subsequent dissocia- 
tion (Fig. 4, model IIB). There is evidence for a Pr interaction 
site proximal to the 3E7 epitope that we have identified [32]. 
In the second possibility, the G, trimer exists in at least two 
states (Fig. 4, model IIC). In one of these alternative states, 
the interactions with j3r in the N-terminal region are relaxed 
to expose the site on a recognized by the antibody. The firs 
remain attached to a via interactions with other segments of 
a. Upon binding of 3E7 to this newly exposed region, re- 
binding of fly to that segment of a would be precluded and 
the complex of 3E7 and a0 would resolve into 3E7-a, and free 
by. The conformation of a, which is captured by 3E7 must be 
distinct from that seen in most of the naturally occurring 
trimers (which retain their pp) and may well be distinct 
from that imposed by the binding of GTP. We have at present 
no tools to assess this possibility. 
I 
c@y- 3WMONO 
3;7 
4 
3E7-a-3WMONO + PY 
II 
A. B. 
4% + a + Pr @r + a + Pr 
317 3;7 
J 4 
a-3E7 + Py a-3E7 + by 
C. 
a-3E7 + py 
Fig. 4. Modes of interaction of 3E7 with G,. In model I, the interaction of 3E7 with immuno-isolated G, is shown. Binding of 3C2 or MONO 
to G, shifts the equilibrium in favor of the trimer. Binding of 3E7 to the Go-antibody complex induces the release of by subunits. In model II 
A, Pr is released as a consequence of 3E7 binding to the small pool of free a subunits available at equilibrium. In model II B, free Pr is gener- 
ated by 3E7 binding to its epitope on & and subsequently displacing & subunits from the trimer. In model II C, a transition state of the tri- 
mer exists (aby+) in which the epitope for 3E7 is exposed. In this model, afly represents a closed state in which the epitope for 3E7 on a, is 
masked. 
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This report shows a ligand in the form of a mAb that can 
induce dissociation of a G-protein trimer in the absence of 
GDPlGTP exchange. The mAb binds to a site on c1 not di- 
rectly involved in guanine nucleotide binding. Using recombi- 
nant clt and mutant a,, the mutant form locked in the GDP- 
bound form was constitutively active toward the transducin 
effector molecule cyclic guanosine monophosphate phospho- 
diesterase in the absence of GDP/GTP exchange and GTPase 
activity [ 121. 
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